These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 22864477

  • 1. Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation.
    Nittner D, Lambertz I, Clermont F, Mestdagh P, Köhler C, Nielsen SJ, Jochemsen A, Speleman F, Vandesompele J, Dyer MA, Schramm A, Schulte JH, Marine JC.
    Nat Cell Biol; 2012 Sep; 14(9):958-65. PubMed ID: 22864477
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The RB protein family in retinal development and retinoblastoma: new insights from new mouse models.
    Bremner R, Chen D, Pacal M, Livne-Bar I, Agochiya M.
    Dev Neurosci; 2004 Sep; 26(5-6):417-34. PubMed ID: 15855771
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Stop the dicing in hematopoiesis: what have we learned?
    Alemdehy MF, Erkeland SJ.
    Cell Cycle; 2012 Aug 01; 11(15):2799-807. PubMed ID: 22801545
    [Abstract] [Full Text] [Related]

  • 6. Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.
    Busch M, Große-Kreul J, Wirtz JJ, Beier M, Stephan H, Royer-Pokora B, Metz K, Dünker N.
    Int J Cancer; 2017 Aug 01; 141(3):549-560. PubMed ID: 28481041
    [Abstract] [Full Text] [Related]

  • 7. Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma.
    Kandalam MM, Beta M, Maheswari UK, Swaminathan S, Krishnakumar S.
    Mol Vis; 2012 Aug 01; 18():2279-87. PubMed ID: 22969266
    [Abstract] [Full Text] [Related]

  • 8. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
    Dalgard CL, Gonzalez M, deNiro JE, O'Brien JM.
    Invest Ophthalmol Vis Sci; 2009 Oct 01; 50(10):4542-51. PubMed ID: 19443717
    [Abstract] [Full Text] [Related]

  • 9. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
    Yang Y, Mei Q.
    Mol Vis; 2015 Oct 01; 21():1307-17. PubMed ID: 26730174
    [Abstract] [Full Text] [Related]

  • 10. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
    Xie C, Lu H, Nomura A, Hanse EA, Forster CL, Parker JB, Linden MA, Karasch C, Hallstrom TC.
    Mol Cancer; 2015 Apr 24; 14():93. PubMed ID: 25907958
    [Abstract] [Full Text] [Related]

  • 11. miR‑34a regulates the chemosensitivity of retinoblastoma cells via modulation of MAGE‑A/p53 signaling.
    Yang G, Fu Y, Lu X, Wang M, Dong H, Li Q.
    Int J Oncol; 2019 Jan 24; 54(1):177-187. PubMed ID: 30387834
    [Abstract] [Full Text] [Related]

  • 12. Unique haploinsufficient role of the microRNA-processing molecule Dicer1 in a murine colitis-associated tumorigenesis model.
    Yoshikawa T, Otsuka M, Kishikawa T, Takata A, Ohno M, Shibata C, Kang YJ, Yoshida H, Koike K.
    PLoS One; 2013 Jan 24; 8(9):e71969. PubMed ID: 24023722
    [Abstract] [Full Text] [Related]

  • 13. Silencing of Dicer1 temporally separates pro- and anti-apoptotic signaling and confers susceptibility to chemotherapy in p53 mutated cells.
    Nekova TS, Kneitz S, Einsele H, Stuhler G.
    Cell Cycle; 2014 Jan 24; 13(14):2192-8. PubMed ID: 24846461
    [Abstract] [Full Text] [Related]

  • 14. miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma.
    Conkrite K, Sundby M, Mukai S, Thomson JM, Mu D, Hammond SM, MacPherson D.
    Genes Dev; 2011 Aug 15; 25(16):1734-45. PubMed ID: 21816922
    [Abstract] [Full Text] [Related]

  • 15. DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.
    Sun X, Tang SC, Xu C, Wang C, Qin S, Du N, Liu J, Zhang Y, Li X, Luo G, Zhou J, Xu F, Ren H.
    J Cell Mol Med; 2015 Jun 15; 19(6):1357-65. PubMed ID: 25702703
    [Abstract] [Full Text] [Related]

  • 16. Regulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development.
    To KH, Pajovic S, Gallie BL, Thériault BL.
    BMC Cancer; 2012 Feb 15; 12():69. PubMed ID: 22336108
    [Abstract] [Full Text] [Related]

  • 17. Dicer cooperates with p53 to suppress DNA damage and skin carcinogenesis in mice.
    Lyle S, Hoover K, Colpan C, Zhu Z, Matijasevic Z, Jones SN.
    PLoS One; 2014 Feb 15; 9(6):e100920. PubMed ID: 24979267
    [Abstract] [Full Text] [Related]

  • 18. Analysis of the p53 pathway in peripheral blood of retinoblastoma patients; potential biomarkers.
    Martínez-Sánchez M, Moctezuma-Dávila M, Hernandez-Monge J, Rangel-Charqueño M, Olivares-Illana V.
    PLoS One; 2020 Feb 15; 15(6):e0234337. PubMed ID: 32502182
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
    Liu Y, Liang G, Wang H, Liu Z.
    Pathol Res Pract; 2019 Dec 15; 215(12):152641. PubMed ID: 31727502
    [Abstract] [Full Text] [Related]

  • 20. The molecular biology of retinoblastoma.
    Brantley MA, Harbour JW.
    Ocul Immunol Inflamm; 2001 Mar 15; 9(1):1-8. PubMed ID: 11262663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.